Skopos Bio
PrivateLast Round
Seed
Oct 12, 2026
Total Funding Raised
$8.3M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Skopos Bio is a biotechnology company that develops precision radiopharmaceutical therapies to target and treat various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skopos Bio Comparables
Compare Skopos Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ARTBIO | 83% | |
| Convergent Therapeutics | 81% | |
| Radionetics Oncology | 79% |
Skopos Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 12, 2026 |
Skopos Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yosemite | Seed |
| Tenmile | Seed |
| Tin Alley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
$8.4M raised from Tenmile and Yosemite.
Skopos Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Skopos Bio's valuation, stock price, and market status.
Is Skopos Bio a public or private company?
Skopos Bio is a private company.
What is the current stock price of Skopos Bio?
Skopos Bio is a private company, so its shares have no public market price. Caplight tracks Skopos Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Skopos Bio worth (valuation)?
Valuation information for Skopos Bio is not publicly available.
Can I buy Skopos Bio stock?
Skopos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Skopos Bio's last funding round?
Skopos Bio's most recent funding round was Seed on October 12, 2026.
Who are the main investors in Skopos Bio?
Key investors in Skopos Bio include Yosemite, Tenmile, Tin Alley Ventures.
Will Skopos Bio IPO soon?
No public IPO plans have been announced for Skopos Bio.
How can I track Skopos Bio secondary market activity?
Caplight tracks bids, offers, and trades in Skopos Bio's shares on secondary markets.